Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
RESEARCH TOOLSreports
Holding DE:BM8?
Track your performance easily
Blogger Sentiment
Sector Average
Bullish
Blogger Article Distribution
36% SeekingAlpha
27% InvestorPlace
18% Zacks
19% Others
The distribution of articles among the main online Financial Blogging platforms.
Top Blogger Bearish Predictions
Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.
Top Blogger Bullish Predictions
Bet on These 5 Stocks With Upgraded Broker Ratings Right Now
The 3 Best Biotech Stocks to Buy in May 2024
Buy These 4 Low-Beta Stocks to Counter Market Volatility
Recent positive articles by top bloggers.
Financial Blogger Predictions
Blogger Performance
Any
Blogger Sentiment
Any
Seeking Alpha
Neutral
BioMarin's Growth Potential And Valuation: Is Now The Right Time To Invest?
Zacks Equity Research
Bullish
Buy These 4 Low-Beta Stocks to Counter Market Volatility
InvestorPlace
Bullish
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
TipRanks Contributor
Bullish
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
FAQ
What do Seeking Alpha bloggers think of DE:BM8?
Seeking Alpha’s Out of Ignorance has a Neutral Sentiment.
What do Motley Fool contributors think of DE:BM8?
Currently there's no blogger sentiment for DE:BM8.
What Is DE:BM8’s Blogger Sentiment?
DE:BM8’s Blogger Sentiment is Bullish.
What was the most recent blogger prediction for DE:BM8?
The most recent blogger prediction for DE:BM8 was made by Swayta Shah , who was Bullish on the stock.
How can I follow the stock ratings of top Top Financial Bloggers?
Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.